Fludeoxyglucose F-18
- Product NDC
- 70681-002
- 11-digit product format
- 706810002
- Labeler code
- 70681
- Product ID
- 70681-002_ab6330a5-d5d3-476d-81a8-f5ca39263173
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fludeoxyglucose F-18
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- The University of Texas Southwestern Medical Center
- Application
- ANDA210265
- Marketing category
- ANDA
- Marketing start
- 2020-06-01
- Marketing end
- 0000-00-00
- Substance
- FLUDEOXYGLUCOSE F-18
- Active strength
- 200 mCi/mL
- Pharmacologic classes
- Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70681-002-30 | 70681000230 | 30 mL in 1 VIAL, GLASS (70681-002-30) | 30 ml | 2020-06-01 | 0000-00-00 | No | No | Current |